Cornerstone Pharmaceuticals
Open
1 Duncan Dr Ste 2
Cranbury, NJ 08512
Cornerstone Pharmaceuticals is a biopharmaceutical company based in Cranbury, NJ, focused on developing innovative antimetabolic therapies for cancer treatment. The company is currently advancing its lead drug candidate, CPI-613 (devimistat), through preclinical models to explore its efficacy in combination therapies.
With a commitment to research and development, Cornerstone Pharmaceuticals aims to revolutionize cancer care by targeting the metabolic pathways that fuel tumor growth. Their strategic approach reflects a dedication to improving patient outcomes through novel therapeutic solutions.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

